Chronic Venous Ulceration (CVU) Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Feb 4, 2021–
The "Chronic Venous Ulceration (CVU) – Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com’s offering.
This ‘Chronic Venous Ulceration (CVU) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Venous Ulceration (CVU) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Prevalent Cases of Venous Ulcers, Diagnosed Prevalent Cases of Venous Ulcers , Diagnosed Prevalent Cases of Venous Leg Ulcers, Type-specific Distribution of Venous Ulcers, Gender-specific Distribution of Venous Ulcers and Age-specific Distribution of Venous Ulcers in the 7MM market covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.
Chronic Venous Ulceration (CVU) Detailed Epidemiology Segmentation

  • The prevalent population of Venous Ulcers in the seven major markets was be 4,231,024 in 2020.
  • The diagnosed prevalent population of Chronic Venous Ulcers in the seven major markets is estimated to be 2,004,905 in 2020.
  • The diagnosed prevalent population of Venous Ulcers in the United States was 2,630,551 in 2020.
  • The diagnosed prevalent population of Venous Leg Ulcers in the United States was estimated to be 2,104,441 in 2020.
  • In the United States, the number of males and females with Venous Ulcers was estimated to 1,052,221 and 1,578,331, respectively, in 2020.
  • Depending on the duration for healing, venous ulcers can be of two types: Acute Venous Ulcers, and Chronic Venous Ulcers. The diagnosed prevalent cases of Acute Venous Ulcers and Chronic Venous Ulcers in the United States were 1,407,345 and 1,223,206 in 2020 .
  • In 2017, the diagnosed prevalence of Venous Ulcers in the United States, was highest in the age group of >70 years, followed by 60-70 years and &lessThan; 60 years with 2,012,513, 402,503, and 100,626 cases, respectively.
  • In the EU5 countries, the diagnosed prevalence of Venous Ulcers was maximum in Germany with 326,283 cases, followed by the France with 229,729 cases in 2017. While, the least number of cases were in Spain, with 176,037 cases in 2017.
  • In Japan, the diagnosed prevalence of Venous Ulcers is estimated to be 490,734 in 2020.

Key Questions Answered

  • What is the disease risk, burden and unmet needs of Chronic Venous Ulceration (CVU)?
  • What is the historical Chronic Venous Ulceration (CVU) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
  • What would be the forecasted patient pool of Chronic Venous Ulceration (CVU) at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Chronic Venous Ulceration (CVU)?
  • Out of the above-mentioned countries, which country would have the highest prevalent population of Chronic Venous Ulceration (CVU)during the forecast period (2020-2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2020-2030)?

Key Topics Covered:
1 Key Insights
2 Executive Summary
3 SWOT Analysis
4 Chronic venous ulceration (CVU) Overview at a Glance
5 Disease Background and Overview: Chronic venous ulceration (CVU)
5.1 Symptoms
5.2 Classification
5.3 Pathophysiology
5.4 Pathogenesis
5.5 Prognostic Indicators
5.6 Clinical Characteristics
5.7 Prevention
5.8 Differential diagnosis
5.9. Diagnosis
5.9.1. Trendelenburg test
5.9.2. Perthes test
5.9.3. Doppler auscultation
5.9.4. Leg venography
5.9.5. Contrast-enhanced computed tomography of the leg
5.9.6. Color Doppler echography of the leg
5.9.7. Magnetic resonance venography of the leg
5.9.8. Venous plethysmography of the lower leg
5.9.9. Ankle-brachial pressure index (ABI or ABPI)
6 Recognized Establishments
7 Epidemiology and Patient Population
7.1 Key Findings
7.2 7MM Prevalent Population of Venous Ulcers
7.3 7MM Diagnosed Prevalent Population of Venous Ulcers
7.4 7MM Diagnosed Prevalent Population of Chronic Venous Ulcers (CVU)
8 7MM Epidemiology of Chronic Venous Ulceration (CVU)
8.1.1 Assumptions and Rationale
8.2 United States
8.2.1 Prevalent Cases of Venous Ulcers in the United States
8.2.2 Diagnosed Prevalent Cases of Venous Ulcers in the United States
8.2.3 Diagnosed Prevalent Cases of Venous Leg Ulcers in the United States
8.2.4 Type-specific Distribution of Venous Ulcers in the United States
8.2.5 Gender-specific Distribution of Venous Ulcers in the United States
8.2.6 Age-specific Distribution of Venous Ulcers in the United States
8.3 EU5 Countries
8.4 Germany
8.5 France
8.6 Italy
8.7 Spain
8.8 United Kingdom
8.9 Japan
9 Publisher Capabilities
For more information about this report visit https://www.researchandmarkets.com/r/d6os9g
View source version on businesswire.com:https://www.businesswire.com/news/home/20210204005729/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 02/04/2021 09:23 AM/DISC: 02/04/2021 09:23 AM
http://www.businesswire.com/news/home/20210204005729/en